发明名称 Selection procedure using prodrug/enzyme system
摘要 The invention relates to a process for the selection from a gene library of a gene encoding an enzyme that is capable of catalysing the conversion of a prodrug to its active drug form. The method comprises contacting a library of lysogenic bacteria with a prodrug that causes activation of bacterial RecA when converted to its active drug form. Activation of RecA causes lysis of the bacteria, so allowing separation of bacteriophage particles released into the medium, and their subsequent genotypic analysis to isolate nucleic acid molecules in the library that encode a desired prodrug-activating enzyme.
申请公布号 AU3065100(A) 申请公布日期 2000.08.07
申请号 AU20000030651 申请日期 2000.01.21
申请人 COBRA THERAPEUTICS LIMITED 发明人 PETER F. SEARLE
分类号 C12N15/10;C12Q1/68 主分类号 C12N15/10
代理机构 代理人
主权项
地址
您可能感兴趣的专利